Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Biomedicines|August 26, 2023
Regulation of 4-HNE via SMARCA4 Is Associated with Worse Clinical Outcomes in Hepatocellular CarcinomaShiori Watabe, Yukari Aruga, Ryoko Kato, et al.
Communications Biology|June 1, 2023
Indirect CRISPR screening with photoconversion revealed key factors of drug resistance with cell-cell interactionsKeisuke Sugita, Iichiroh Onishi, Ran Nakayama, et al.
Cancers|November 27, 2024
GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic StrategiesHirotomo Takahara, Takumi Kanazawa, Haruna Oshita, et al.
European Urology Open Science|February 6, 2023
Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell CarcinomaHajime Tanaka, Shohei Fukuda, Koichiro Kimura, et al.
Clinical and Experimental Nephrology|February 17, 2021
Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidneyNaohiro Takahashi, Hiroaki Kikuchi, Ayaka Usui, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2024
Prognostic Impact and Genomic Backgrounds of Renal Parenchymal Infiltration or Micronodular Spread in Nonmetastatic Clear Cell Renal Cell CarcinomaHajime Tanaka, Yuki Fukawa, Kouhei Yamamoto, et al.
International Journal of Molecular Sciences|November 11, 2022
Spatial and Quantitative Analysis of Tumor-Associated Macrophages: Intratumoral CD163-/PD-L1+ TAMs as a Marker of Favorable Clinical Outcomes in Triple-Negative Breast CancerHajime Shinohara, Maki Kobayashi, Kumiko Hayashi, et al.
International Journal of Molecular Sciences|September 14, 2024
Lipid Peroxidation Regulators GPX4 and FSP1 as Prognostic Markers and Therapeutic Targets in Advanced Gastric CancerKazuhiro Tamura, Yoshinobu Tomita, Takumi Kanazawa, et al.
Pageof 12